PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
ID: 355903Type: Forecasted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$900K - $1M

Eligible Applicants

For-Profit Organizations

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355903
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study focused on assessing optimal strategies for integrating postexposure prophylaxis (PEP) packs into existing clinical services for HIV and STI prevention, particularly targeting gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) in communities with high HIV diagnosis rates. The funding, which ranges from $900,000 to $1,200,000, is part of a total program budget of $4,800,000, with one award expected to be made. Interested applicants, specifically for-profit organizations, should note that applications must be submitted electronically by February 12, 2025, with an estimated award date of August 15, 2025. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.

    Point(s) of Contact
    Amy Yang
    (404) 718-8836
    AYang@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Developing and Testing Pilot Prevention Interventions to Reduce Sexual Risk Behavior and Enhance PrEP Use among HIV-negative Black and Hispanic Substance-using Gay, Bisexual, and Other MSM
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity aimed at developing and testing pilot prevention interventions to reduce sexual risk behavior and enhance PrEP use among HIV-negative Black and Hispanic substance-using gay, bisexual, and other men who have sex with men (MSM). This initiative seeks to support the design and implementation of two behavioral interventions, one targeting Black MSM and the other targeting Hispanic MSM, specifically focusing on those who report substance use before or during unprotected anal sex. The funding, which ranges from $400,000 to $475,000 per award, totals an estimated $2,850,000 for two awards, with applications due by February 13, 2025, and anticipated project start dates in September 2025. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836 for further information.
    Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the implementation and evaluation of PrEPmate, a mobile health intervention aimed at enhancing HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) and transgender women of color. The initiative seeks to facilitate the deployment of PrEPmate at three clinical sites in the southern United States, focusing on improving patient adherence and retention in PrEP care through tailored interactive content, reminders, and a monitoring dashboard. With an estimated total program funding of $3 million and one expected award, interested applicants can reach out to Charles Collins at cwc4@cdc.gov or by phone at 404-639-0966. The application deadline is set for March 7, 2025, with project commencement anticipated on July 1, 2025.
    Improving prevention, treatment, and care services for HIV and TB for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at improving prevention, treatment, and care services for HIV and tuberculosis (TB) for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative focuses on providing high-quality HIV clinical services, particularly for individuals of Haitian descent, by enhancing access to HIV testing, treatment, and TB preventive therapy, while ensuring lifelong retention in care to achieve viral suppression. This funding is crucial for addressing health disparities and improving health outcomes in vulnerable populations, with an estimated total fiscal year funding amount of $5,600,000 for Year 1, and applications are expected to be submitted electronically by February 17, 2025. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information.
    Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at enhancing the capacity for HIV prevention, diagnosis, and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative will focus on improving access to HIV prevention services, increasing knowledge of HIV status through enhanced testing strategies, and supporting treatment outcomes for individuals living with HIV, particularly in El Salvador, Guatemala, Honduras, Nicaragua, and Panama. The estimated total funding for the first year is approximately $17 million, with the expectation of awarding two grants, and applications must be submitted electronically by February 17, 2025. For further inquiries, interested applicants can contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    Ending HIV as a public health threat by sustaining and accelerating a comprehensive HIV response in India under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at ending HIV as a public health threat in India through the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to support the National AIDS Control Organization in sustaining and accelerating HIV epidemic control by implementing innovative, evidence-based strategies across the prevention to treatment continuum. The initiative is critical for enhancing HIV and TB prevention efforts, improving case finding, and ensuring linkage to care, with an anticipated funding amount of approximately $3,000,000 for the first year, subject to availability. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov, with applications due by February 17, 2025, and awards expected to be announced by September 30, 2025.
    Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at implementing combination prevention solutions to achieve epidemic control among high-risk populations in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to support evidence-based interventions that promote HIV testing services, pre-exposure prophylaxis, and other critical health services, particularly targeting vulnerable groups such as adolescents and young people in various community settings. The initiative aligns with South Africa's HIV National Strategic Plan and emphasizes the importance of comprehensive health interventions to reduce HIV transmission and improve overall health outcomes. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information, with an estimated total funding of $25 million for the first fiscal year and a projected application deadline of February 17, 2025.
    Transgender Women’s Interventions: Pilot and Evaluation
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control - NCHHSTP is forecasting a funding opportunity titled "Transgender Women’s Interventions: Pilot and Evaluation," aimed at supporting HIV prevention services for transgender women. This cooperative agreement seeks applications from organizations that are embedded within the transgender community and have a proven history of providing HIV prevention services, with the ability to operate in up to three service areas, including those that may cross state lines. The program is critical for addressing health disparities and enhancing the effectiveness of HIV prevention interventions tailored for transgender women. The estimated total program funding is $8,400,000, with eight awards anticipated, and applications must be submitted electronically by 11:59 pm ET on October 9, 2024. For further inquiries, interested applicants can contact Andrea Moore at AMoore@cdc.gov or by phone at 404-639-6262.
    Sustaining the HIV/TB response through targeted technical assistance to the Eswatini Ministry of Health to deliver quality, equitable, and patient centered clinical HIV/TB services (STEPS) under PEPFAR
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Sustaining the HIV/TB response through targeted technical assistance to the Eswatini Ministry of Health to deliver quality, equitable, and patient-centered clinical HIV/TB services (STEPS) under PEPFAR." This initiative aims to provide technical assistance to the Eswatini Ministry of Health to enhance programmatic leadership and oversight capacities, ultimately working towards the goal of ending HIV as a public health threat in Eswatini by 2030. The program will focus on increasing ownership and accountability within the Ministry, implementing evidence-based interventions, and strengthening quality management processes for integrated chronic disease management. Interested applicants can expect an estimated total funding amount of $2,500,000 for the first year, with applications due by February 17, 2025. For further inquiries, contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at supporting the implementation of comprehensive HIV prevention and treatment programs in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative seeks to enhance the capacity of the Zimbabwe Ministry of Health and Child Care to deliver critical HIV services, including differentiated testing, treatment linkage, viral load monitoring, and management of advanced HIV disease, while also addressing non-communicable diseases and TB-HIV collaboration. This funding is vital for improving health outcomes among key populations, particularly children and young women, and will involve collaboration with faith-based and government-supported health facilities. Interested applicants can expect an estimated total funding amount of $10 million for the first year, with applications due by February 17, 2025, and the anticipated award date set for September 30, 2025. For further inquiries, applicants may contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    Strengthening civil society organizations' capacity and coordination for accelerated HIV epidemic control in Uganda through supporting implementation of comprehensive HIV/AIDS prevention and treatment for key and priority populations under PEPFAR
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at strengthening the capacity and coordination of civil society organizations (CSOs) in Uganda to enhance HIV epidemic control under the PEPFAR initiative. This initiative focuses on implementing comprehensive HIV/AIDS prevention and treatment services for key and priority populations, including marginalized groups such as female sex workers, men who have sex with men, and people who inject drugs, who collectively contribute significantly to new HIV infections in the region. The anticipated funding for the first year is approximately $10 million, with two awards expected, and applications must be submitted electronically by February 17, 2025, to be considered for funding. For further inquiries, interested applicants can contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.